223.00
-13.10
(-5.55%)
At close: January 30 at 5:24:49 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,765.00
-28,566.00
1,059.00
-23,561.00
-19,753.00
Investing Cash Flow
4,799.00
46,449.00
-46,159.00
9,745.00
13,038.00
Financing Cash Flow
14,110.00
6,423.00
1,632.00
36,930.00
29,865.00
End Cash Position
28,144.00
35,992.00
11,936.00
56,277.00
33,183.00
Interest Paid Supplemental Data
8.00
10.00
13.00
13.00
20.00
Capital Expenditure
-291.00
-674.00
-413.00
-340.00
-64.00
Issuance of Capital Stock
14,070.00
6,625.00
148.00
30,865.00
5,127.00
Issuance of Debt
--
--
--
--
25,147.00
Repayment of Debt
-53.00
-54.00
-32.00
-20.00
-26.00
Repurchase of Capital Stock
-23.00
-37.00
-17.00
-54.00
-27.00
Free Cash Flow
-23,056.00
-29,240.00
646.00
-23,901.00
-19,817.00
12/31/2020 - 9/8/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ORMP.TA Oramed Pharmaceuticals Inc.
796.60
-0.75%
CGEN.TA Compugen Ltd.
853.60
+2.14%
PPBT.TA Purple Biotech Ltd
5.90
-4.84%
BLRX.TA BioLineRx Ltd.
2.4000
-25.00%
ENLV.TA Enlivex Therapeutics Ltd.
396.00
-0.63%
XTLB XTL Biopharmaceuticals Ltd.
1.5899
-1.25%
EVGN Evogene Ltd.
1.5700
+1.29%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
-99.00%
PLUR Pluri Inc.
4.4800
+2.28%
PXMD PaxMedica, Inc.
0.0310
0.00%